STOCK TITAN

Avant Brands Inc. Announces Voting Results From 2025 Annual General Meeting of Shareholders

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Avant Brands Inc. (AVTBF) held its 2025 Annual General Meeting on May 30, with 16.19% of total issued shares (1,752,490 shares) represented. Shareholders approved all proposed items including the election of six board nominees, reappointment of Ernst & Young LLP as auditor, approval of deferred share unit plan and its amendments, long term incentive plan and its amendments, and the repricing of certain warrants and convertible debentures from July 26, 2024. The complete voting results have been filed on SEDAR+ for public access.
Avant Brands Inc. (AVTBF) ha tenuto la sua Assemblea Generale Annuale 2025 il 30 maggio, con il 16,19% delle azioni emesse totali (1.752.490 azioni) rappresentate. Gli azionisti hanno approvato tutte le proposte, inclusa l'elezione di sei candidati al consiglio, la riconferma di Ernst & Young LLP come revisore, l'approvazione del piano di unità azionarie differite e delle sue modifiche, il piano di incentivi a lungo termine e le sue modifiche, nonché il ricalcolo del prezzo di alcuni warrant e obbligazioni convertibili a partire dal 26 luglio 2024. I risultati completi delle votazioni sono stati depositati su SEDAR+ per l'accesso pubblico.
Avant Brands Inc. (AVTBF) celebró su Junta General Anual 2025 el 30 de mayo, con el 16,19% del total de acciones emitidas (1.752.490 acciones) representadas. Los accionistas aprobaron todos los puntos propuestos, incluyendo la elección de seis candidatos para el consejo, la reelección de Ernst & Young LLP como auditor, la aprobación del plan de unidades de acciones diferidas y sus enmiendas, el plan de incentivos a largo plazo y sus modificaciones, así como la revalorización de ciertos warrants y bonos convertibles a partir del 26 de julio de 2024. Los resultados completos de la votación se han presentado en SEDAR+ para acceso público.
Avant Brands Inc. (AVTBF)는 5월 30일 2025년 연례 주주총회를 개최했으며, 총 발행 주식의 16.19%(1,752,490주)가 참석했습니다. 주주들은 6명의 이사회 후보 선출, Ernst & Young LLP의 감사 재선임, 이연 주식 단위 계획 및 그 개정안 승인, 장기 인센티브 계획 및 그 개정안 승인, 2024년 7월 26일부터 일부 워런트 및 전환사채의 가격 재조정을 포함한 모든 제안 사항을 승인했습니다. 전체 투표 결과는 SEDAR+에 공개되어 있습니다.
Avant Brands Inc. (AVTBF) a tenu son Assemblée Générale Annuelle 2025 le 30 mai, avec 16,19 % des actions émises totales (1 752 490 actions) représentées. Les actionnaires ont approuvé toutes les résolutions proposées, y compris l’élection de six candidats au conseil d’administration, la reconduction d’Ernst & Young LLP en tant qu’auditeur, l’approbation du plan d’unités d’actions différées et ses modifications, le plan d’incitation à long terme et ses amendements, ainsi que la révision du prix de certains bons de souscription et obligations convertibles à compter du 26 juillet 2024. Les résultats complets des votes ont été déposés sur SEDAR+ pour consultation publique.
Avant Brands Inc. (AVTBF) hielt am 30. Mai seine Hauptversammlung 2025 ab, bei der 16,19 % der ausgegebenen Aktien (1.752.490 Aktien) vertreten waren. Die Aktionäre stimmten allen vorgeschlagenen Punkten zu, darunter die Wahl von sechs Vorstandsmitgliedern, die Wiederbestellung von Ernst & Young LLP als Wirtschaftsprüfer, die Genehmigung des Plans für aufgeschobene Aktienanteile und dessen Änderungen, des langfristigen Anreizplans und dessen Änderungen sowie die Neuansetzung des Preises bestimmter Warrants und Wandelanleihen ab dem 26. Juli 2024. Die vollständigen Abstimmungsergebnisse wurden auf SEDAR+ zur öffentlichen Einsicht eingereicht.
Positive
  • None.
Negative
  • None.

KELOWNA, BC / ACCESS Newswire / May 30, 2025 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, held its annual general meeting of shareholders of the Company (the "Shareholders") on May 30, 2025 (the "Meeting").

1,752,490 of the Company's issued and outstanding common shares, representing 16.19% of the total issued and outstanding common shares of the Company, were represented in person or by proxy at the Meeting.

The complete voting results from the Meeting are as follows:

1. Election of Directors

Each of the six nominees listed in the management information circular of the Company dated April 22, 2025 (the "Circular") were elected to hold office until the next annual meeting of Shareholders or until their successor is duly elected or appointed. Proxies were tabulated as follows:

2. Ernst & Young LLP was re-appointed as auditor ("Auditor") of the Company for the ensuing year at a remuneration to be fixed by the Company's Board of Directors.

3. The Company's deferred share unit plan was approved.

4. The amendments to the Company's deferred share unit plan were approved.

5. The Company's long term incentive plan was approved.

6. The amendments to the Company's long term incentive plan were approved.

7. The repricing of certain warrants and convertible debentures originally issued by the Company on July 26, 2024 pursuant to a private placement was approved.

The results on all matters voted at the Meeting are reported in the Report of Voting Results, filed on SEDAR+ under the Company's profile at www.sedarplus.com.

Neither the TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSX) accepts responsibility for the adequacy or accuracy of this release.

About Avant Brands Inc.

Avant is an innovative, market-leading premium cannabis company. Avant has multiple operational production facilities across Canada, which produce high-quality, handcrafted cannabis products based on unique and exceptional cultivars.

Avant offers a comprehensive product portfolio catering to recreational, medical, and export markets. Avant's consumer brands, including BLK MKT™, Tenzo™, Cognōscente™, flowr™ and Treehugger™, are available in key recreational markets across Canada. Avant's products are distributed globally to Australia, Israel and Germany, with its flagship brand BLK MKT™ currently being sold in Israel. Additionally, Avant's medical cannabis brand, GreenTec™, serves qualified patients nationwide through its GreenTec Medical portal and trusted medical cannabis partners.

Avant is a publicly traded corporation listed on the TSX (TSX:AVNT) and accessible to international investors through the OTCQX Best Market (OTCQX:AVTBF) and Frankfurt Stock Exchange (FRA:1BU0). Headquartered in Kelowna, British Columbia, Avant operates in strategic locations including British Columbia, Alberta, and Ontario.

For more information about Avant, including access to investor presentations and details about its consumer brands, please visit www.avantbrands.ca.

For further inquiries, please contact:
Investor Relations at Avant Brands Inc.
1-800-351-6358
ir@avantbrands.ca

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:

This news release includes certain "forward-looking information" as defined under applicable Canadian securities legislation, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and operating performance. Forward-looking information is often identified by the words "may", "would", "could", "should", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" or similar expressions and includes information regarding the Meeting; filing and mailing of the Circular; and the proposed Repricing Amendments. Forward-looking information is necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking information.

Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although the Company believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of the Company. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: risk related to the ability to obtain additional financing; limited operating history; regulatory and licensing risks; changes in consumer demand and preferences; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in the Company's annual information form dated February 28, 2025, filed with Canadian securities regulators and available on the Company's profile on SEDAR+ at www.sedarplus.ca.

Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information, which speak only as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

SOURCE: Avant Brands Inc.



View the original press release on ACCESS Newswire

FAQ

What was the voter turnout at Avant Brands (AVTBF) 2025 AGM?

The voter turnout at Avant Brands' 2025 AGM was 16.19% of total issued shares, representing 1,752,490 shares.

What key proposals were approved at Avant Brands' 2025 Annual General Meeting?

Shareholders approved the election of six directors, reappointment of Ernst & Young as auditor, deferred share unit plan and amendments, long term incentive plan and amendments, and repricing of certain warrants and convertible debentures.

Who was appointed as the auditor for Avant Brands (AVTBF) at the 2025 AGM?

Ernst & Young LLP was reappointed as the auditor of Avant Brands for the ensuing year.

What changes to financial instruments were approved at Avant Brands' 2025 AGM?

Shareholders approved the repricing of certain warrants and convertible debentures that were originally issued on July 26, 2024 through a private placement.
Avant Brands Inc

OTC:AVTBF

AVTBF Rankings

AVTBF Latest News

AVTBF Stock Data

7.08M
5.98M
13.77%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
Canada
Kelowna